Leadership Built on Trust, Enabling Innovation
Inventera's leadership brings end-to-end expertise, from drug R&D to commercialization,
bridging science and business across diagnostics and therapeutics.
Founder & CEO & CTO
Tae-Hyun Shin
PhDAdvancing Inventera's vision from science to market.
Key Achievments
- Inventor of Invinity™, Inventera's nanomedicine platform
- Led development and execution across key programs, including INV-002
- Selected as an Innovator Under 35 by MIT Technology Review
Education & Experience
- Ph.D. and B.S. in Chemistry, Yonsei University
- Research Assistant Professor, Research Institute for Radiological Science, Yonsei University College of Medicine
- Postdoctoral Researcher, Industry-Academic Cooperation Foundation, Yonsei University
Chief Business Officer
Taesook Yoo
RPhBringing Inventera’s technology and pipelines to domestic and global markets.
Key Achievments
- Built business partnership with domestic and global pharma companies
- Led strategic collaborations and technology transfer / licensing projects
- Drove business expansion leveraging a strong network across the Korean and global pharmaceutical industry
Education & Experience
- B.S. in Pharmacy, Seoul National University
- President & CEO, Bracco Imaging Korea
- Deputy CEO, Guerbet Korea
- President & CEO, llyang Pharmaceutical Co., Ltd.
- President, Korea Industrial Pharmacists Association
- Vice President, Korean Pharmaceutical Association
Head of Research Institute
Ji-wook Kim
PhDLeading Inventera's drug pipeline development and R&D operations.
Key Achievments
- Led nanomedicine research and pipeline development
- Delivered clinical translational research outcomes
- Selected as a Promising Young Scientist by the Korean Academy of Science and Technology (KAST)
Education & Experience
- Ph.D. and B.S. in Chemistry, Yonsei University
- Postdoctoral Researcher, University of South Carolina
- Postdoctoral Researcher, Industry–Academic Cooperation Foundation, Yonsei University
Chief Financial Officer
Yongjae Kwon
Building a sustainable growth engine through financial strategy and investor communications.
Key Achievments
- Designed financing strategy and fundraising structures for biotech companies
- Established corporate operations and governance / management systems
- Built IPO and disclosure (filing) frameworks and processes
Education & Experience
- B.A. in Business Administration, University of Ulsan
- Head of Strategic Planning Office, ABKO
- CFO, PR Technology Inc.
- Team Lead, IR / PR / Disclosure, Hugel
From Expertise to Real-World Impact
